Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China
· Delayed Price · Currency is CNY 37.08
+2.98 (8.74%)
Mar 11, 2026, 9:25 AM CST
SHE:300683 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,854 | 3,121 | 4,727 | 4,322 | 7,273 | 4,225 | Upgrade
|
| Market Cap Growth | 54.44% | -33.98% | 9.35% | -40.56% | 72.12% | 35.86% | Upgrade
|
| Enterprise Value | 4,179 | 2,310 | 3,665 | 3,553 | 6,267 | 3,146 | Upgrade
|
| Last Close Price | 37.08 | 23.70 | 35.90 | 35.19 | 59.21 | 40.64 | Upgrade
|
| PE Ratio | - | - | - | - | 262.98 | - | Upgrade
|
| Forward PE | - | 21.83 | 21.83 | 21.83 | 21.83 | 21.83 | Upgrade
|
| PS Ratio | 7.83 | 4.81 | 7.85 | 6.28 | 11.83 | 8.06 | Upgrade
|
| PB Ratio | 2.16 | 1.29 | 1.89 | 1.85 | 3.10 | 2.45 | Upgrade
|
| P/TBV Ratio | 2.67 | 1.66 | 2.44 | 2.25 | 3.79 | 3.26 | Upgrade
|
| P/OCF Ratio | - | 137.55 | 889.42 | 81.51 | 601.62 | - | Upgrade
|
| EV/Sales Ratio | 6.74 | 3.56 | 6.09 | 5.16 | 10.20 | 6.00 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 203.04 | 279.54 | - | Upgrade
|
| EV/FCF Ratio | -29.37 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.03 | 0.04 | 0.04 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 4.12 | 3.64 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.30 | -0.34 | -0.41 | -0.41 | -0.47 | -0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | 17.73 | 28.40 | 14.48 | -54.50 | -49.06 | 160.77 | Upgrade
|
| Net Debt / FCF Ratio | 4.81 | 40.67 | 6.33 | 7.89 | 4.68 | 7.45 | Upgrade
|
| Asset Turnover | 0.22 | 0.22 | 0.21 | 0.26 | 0.25 | 0.24 | Upgrade
|
| Inventory Turnover | 3.68 | 3.37 | 3.11 | 3.74 | 3.75 | 3.41 | Upgrade
|
| Quick Ratio | 4.11 | 3.23 | 3.88 | 4.46 | 5.85 | 3.35 | Upgrade
|
| Current Ratio | 4.60 | 3.60 | 4.30 | 5.07 | 6.35 | 3.62 | Upgrade
|
| Return on Equity (ROE) | -8.19% | -3.01% | -5.31% | -0.34% | 1.48% | -1.47% | Upgrade
|
| Return on Assets (ROA) | -3.12% | -2.46% | -3.07% | -0.78% | -0.34% | -1.01% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.63% | -7.61% | -9.79% | -2.57% | -1.34% | -5.32% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.80% | -4.50% | -5.30% | -1.40% | -0.50% | -1.90% | Upgrade
|
| Earnings Yield | -3.87% | -2.22% | -2.56% | -0.33% | 0.38% | -0.59% | Upgrade
|
| FCF Yield | -2.93% | -0.65% | -3.43% | -2.80% | -3.23% | -3.16% | Upgrade
|
| Dividend Yield | 0.38% | 0.55% | - | - | - | - | Upgrade
|
| Payout Ratio | - | - | - | - | 0.22% | - | Upgrade
|
| Buyback Yield / Dilution | 3.98% | -0.71% | -1.86% | -19.91% | -2.00% | -0.91% | Upgrade
|
| Total Shareholder Return | 4.38% | -0.17% | -1.86% | -19.91% | -2.00% | -0.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.